Filament Health Corp Stock Today
FLHLF Stock | USD 0.04 0.0006 1.52% |
Performance5 of 100
| Odds Of DistressLess than 30
|
Filament Health is trading at 0.04 as of the 4th of December 2024. This is a 1.52% increase since the beginning of the trading day. The stock's lowest day price was 0.0251. Filament Health has about a 30 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Filament Health Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of August 2024 and ending today, the 4th of December 2024. Click here to learn more.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants conducts genetic research performs extraction procedures runs in-house trials and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. The company has 174.95 M outstanding shares. More on Filament Health Corp
Moving against Filament OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Filament OTC Stock Highlights
Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Filament Health Corp [FLHLF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.08 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Filament Health's market, we take the total number of its shares issued and multiply it by Filament Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Filament Health Corp classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 174.95 M outstanding shares.
Filament Health Corp has accumulated about 3 M in cash with (5.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Filament Health Probability Of Bankruptcy
Ownership AllocationFilament Health holds a total of 174.95 Million outstanding shares. Filament Health Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.23 percent of Filament Health Corp outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Filament Ownership Details
Filament Health Corp Risk Profiles
Mean Deviation | 11.01 | |||
Semi Deviation | 12.17 | |||
Standard Deviation | 16.02 | |||
Variance | 256.79 |
Filament Stock Against Markets
Picking the right benchmark for Filament Health otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Filament Health otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Filament Health is critical whether you are bullish or bearish towards Filament Health Corp at a given time. Please also check how Filament Health's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Filament Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
All Next | Launch Module |
Filament Health Corporate Management
Elected by the shareholders, the Filament Health's board of directors comprises two types of representatives: Filament Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Filament. The board's role is to monitor Filament Health's management team and ensure that shareholders' interests are well served. Filament Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Filament Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jon Conlin | Corp Director | Profile | |
Jeff Fellows | Head Regulatory | Profile | |
Benjamin Lightburn | CEO CoFounder | Profile | |
Tom Kineshanko | CoFounder | Profile | |
Warren Duncan | Chief Officer | Profile | |
Lisa Ranken | Chief Officer | Profile | |
Anna Cordon | Director Communications | Profile |
Other Information on Investing in Filament OTC Stock
Filament Health financial ratios help investors to determine whether Filament OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Filament with respect to the benefits of owning Filament Health security.